<DOC>
	<DOCNO>NCT02036177</DOCNO>
	<brief_summary>The SCu300A IUB™ ( hereafter IUB™ ) evaluate safety effectiveness comparison market approve standard T shape IUD contain 380sq.mm . copper : Comparison objective parameter - Pregnancy rate , perforation , expulsion malposition rate , change endometrial thickness , rate complication infection anemia discontinuation rate 1 year . Comparison Subjective parameter - pain insertion , menstrual characteristic pain , bleed correlation bleeding pattern prior insertion . Physician opinion : ease use insertion removal . Subject satisfaction . It expect subject use copper IUB demonstrate less safety event , equal effectiveness equal improve menstrual bleeding pain related profile compare user T shape copper IUD .</brief_summary>
	<brief_title>Multivariate Assessment IUB Intrauterine Device Compared With T380A IUD</brief_title>
	<detailed_description />
	<mesh_term>Copper</mesh_term>
	<criteria>Inclusion criterion : Adult female age 2542 Free willing fully comply treatment process Healthy woman seek LARC Married steady relationship ( least 1 year ) Blood hemoglobin &gt; 11.5gr % Signed informed consent form If take COCP least one cycle use OC Exclusion criterion : Use IUB/IUD emergency contraception A previously place IUD remove Pregnancy suspicion pregnancy Use contraception method ( condom either male female , oral contraceptive , diaphragm , spermicide , hormonal patch , injection ring , cervical cap ) History pelvic inflammatory disease , recent remote . Postpartum endometritis postabortal endometritis past 3 month Mucupurulent cervicitis Endometrial thickness 12 mm insertion date Known anemia ( except thalassemia , sickle cell , chronic anemia ) History previous IUD complication Dysfunctional uterine bleeding Undiagnosed uterine bleeding Malignancy suspect malignant disease female inner outer genitalia Distortions uterine cavity uterine fibroid know anatomical abnormality Known intolerance allergy nitinol copper and/or copper IUDs Wilson 's disease . Medication may interfere subject 's ability complete protocol Use injectable contraception previous year Any significant disease condition could interfere subject 's ability complete protocol A history alcohol drug abuse Known infection human immunodeficiency virus ( HIV ) , Hepatitis B Hepatitis C Pregnancy pregnancy plan year Enrollment ( less 30 day complete another study ) plan enrol another study</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>